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1. Introduction 
The non-thrombogenic biomaterial has been received a great interest for the development of 
medical devices or implants in these few decades. When any medical device contacts with 
flowing blood or internal organs, the material surface of device should avoid the initiation 
of the process leading to a thrombosis. Such a biocompatible property of artificial 
biomaterials is a very important factor to use the materials for long-term implantable 
devices, extracorporeal circulation and intravenous catheters sensors. Although a lot of 
medical devices are used clinically, the universal non-thrombogenic material has not yet 
been developed and these devices have been limited to be used for long-term implantation.  
On the other hand, phospholipids are the main components of cell membranes and act as 
interesting substances in biological and biomedical fields (Chapman, 1968; Gregoriadis & 
Allison, 1980; Hayward & Chapman, 1984). Several attempts have been made to translate the 
natural compatibility between blood and phospholipid membranes for the application of 
medical devices. The phosphorylcholine (PC) group is a polar component of phospholipid 
molecules, which covers the surface of cell membranes. It has been well known that synthetic 
polymer materials containing PC group exhibit biocompatibility including blood compatibility 
(Sugiyama et al., 1995; Ohishi et al., 1997; Gong et al., 2005). Especially, the so-called MPC 
polymer, which is typically a copolymer of 2-methacryloyloxyethyl phosphorylcholine (MPC) 
with butyl methacrylate, has been reported as ideal non-thrombogenic and excellent 
biocompatible materials (Ishihara et al., 1990a, 1990b, 1991; Ueda et al., 1992). This polymer was 
designed based on the inspiration from the outer surface of the cell membrane, i.e. the 
biomembrane, which is mainly constructed of natural phospholipid molecules. In particular, 
the adhesion and the activation of platelets were completely suppressed on the surface of the 
MPC polymer, and the amount of plasma proteins adsorbed on the surface of MPC polymer 
film was clearly decreased. Since PC group consists of a zwitterion, MPC polymer behaves as 
an entire neutrality molecule and exhibited no interaction with specific ions in the living 
organism. Furthermore, the applications to medical devices and other uses have been greatly 
advanced in these years (Sawada et al., 2006; Patel et al., 2005; Iwasaki et al., 1997; Uchiyama et 
al., 2002; Ye et al., 2006; Goda & Ishihara, 2006; Snyder et al., 2007). Therefore, MPC polymers 
are useful polymeric biomaterials not only in the biomedical field but also in the tissue 
engineering and bioengineering fields. 
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However, most of MPC polymers do not possess the enough durability to several solvents 
such as alcohols, the thermal stability and the mechanical strength, which were derived 
from the polymethacrylate type main chain structure. Then, if these physical properties of 
MPC polymers improved satisfactorily while maintaining the excellent biocompatibility, 
novel biocompatible polymer materials could be developed. Recently, we have succeeded in 
synthesizing a novel diamine monomer containing PC moiety and preparing aromatic 
polyamides and poly(urethane-urea)s from the monomer (Nagase et al., 2007, 2008; 
Horiguchi et al., 2008). In addition, PC group was also introduced into ethyl cellulose by 
polymer reaction using carboxylic compound containing PC group (Tadokoro et al., 2007). It 
was found that the obtained polymers exhibited the excellent biocompatibility derived from 
PC unit in addition to the processability, the durability to solvents, the thermal stability and 
the mechanical strength, which were derived from the main chain components.  
In this chapter, the synthetic pathway of novel aromatic diamine monomers containing PC 
moiety will be described at first. Then, we will describe the preparations of high molecular 
weight aromatic polyamides and poly(urethane-urea)s containing PC group, which are 
obtained by polycondensation and polyaddition using these monomers. Furthermore, the 
physical properties such as solubility, thermal property, biological function as blood 
compatibility, and surface property of the obtained polyamides will be discussed to reveal 
the possibility of a durable biocompatible polymer material. 
2. Diamine monomer containing phospholipid moiety 
At first, our history of development of novel aromatic diamine compound will be described. 
The synthetic route of the diamine monomer containing PC group, 2-(3,5-
diaminophenylcarbonyloxy)ethyl phosphorylcholine (DAPC), is shown in Scheme 1. The 
starting material, a dinitro compound (1), was prepared by the reaction of 3,5-dinitrobenzoyl 
chloride with excess amount of ethylene glycol in good yield. Then, the reaction of 1 with  
2-chloro-2-oxo-1,3,2-dioxaphospholane (COP) yielded a phospholane compound (2), which 
was an intermediate of phosphorylcholine compound. The purification of 2 by a silica-gel 
column chromatography was difficult because it was easily hydrolyzed. However, the 
extraction of the crude products with chloroform followed by washing with distilled water 
gave the pure product of 2. Next, DAPC was obtained by opening the cyclic phosphoric ester 
moiety of 2 with trimethylamine, followed by the reduction of the nitro groups of 3 with H2 
catalyzed by Pd. The chemical structure of DAPC was confirmed by IR and 1H-NMR spectra. 
In the IR spectra of DAPC, a broad adsorption peak in the region of 3400-3150 cm-1 was 
observed as the amino groups, and the PC group was identified by the peak at 1228 and 1076 
cm-1. This aromatic diamine compound, DAPC, would be a useful monomer for the syntheses 
of various aromatic polymers, such as polyamides, polyimides, polyureas and poly(urethane-
urea)s that have PC group in the side chain. 
Next, the synthesis of copolyamide was carried out by the polycondensation of DAPC with 
isophthaloyl chloride and another diamine comonomer. As the comonomer, 4,4’-diamino-
3,3’-dimethyldiphenylmethane was used to make the polymer soluble in some solvents. 
Namely, the aromatic copolyamides containing PC group could be successfully prepared 
from DAPC, whose composition of DAPC unit was 21 mol%. A homopolyamide without PC 
group was prepared from 4,4’-diamino-3,3’-dimethyldiphenylmethane and isophthaloyl 
chloride to compare the biocompatible properties with PC-containing copolyamide. 
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Scheme 1. Synthesis of diamine monomer containing PC moiety (DAPC). 
The thin films of these polyamides were prepared by coating of the NMP solutions of the 
polymers on poly(ethylene terephthalate) (PET) plates, and the blood compatibility of the 
coating films was evaluated by contacting the coated plates with a human blood. Fig. 1 
shows SEM pictures of the two film surfaces of PC-containing copolyamide and 
homopolyamide without PC unit after contact with human platelet-rich plasma (PRP) for 60 
min. The numerous adherent platelets on the homopolyamide surface were observed as 
large aggregates. In contrast, the platelets were significantly suppressed on the copolyamide 
film surfaces as shown in Fig. 1(a). These results clearly indicated that PC-containing 
copolyamide exhibited the excellent blood compatibility and PC unit in the copolyamide 
was an important element to develop the blood compatibility. Furthermore, the composition 
of the PC unit was a dominant factor in the reduction of the platelet adhesion (Nagase et al., 
2007). These results would be due to the PC unit located at the surface of the polymer film, 
where the surface is covered with PC unit, and the interaction between the polymer surface 
and blood ingredients such as cells and platelets is very weak. 
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Fig. 1. SEM pictures of polyamide film surfaces with and without PC unit after contact with 
human PRP for 60 min at 37°C. (x 2,000) 
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However, the molecular weight and the PC content of copolyamides from DAPC were not 
enough to produce a self-standing film and to exhibit the higher biocompatibility, 
respectively, which would be due to the low reactivity and also the highly hygroscopic 
property of DAPC. Thus, we have projected a new structure of high molecular weight 
polymer in order to create the practical biomaterials for several applications, which exhibit 
the excellent biocompatibility in addition to the processability, the durability to solvents, the 
thermal stability and the mechanical strength. For this purpose, we designed a new diamine 
monomer containing PC group, 2-[3,5-bis(4-aminophenoxy)phenylcarbonyloxy]ethyl 
phosphorylcholine (BAPPC in Scheme 2), to solve these problems of DAPC. BAPPC is 
expected to show the higher reactivity in the polymerization than DAPC, which would be 
due to the relatively higher reactive amino groups on p-position of phenoxy groups.  
The synthetic route of the new PC-containing diamine monomer is outlined in Scheme 2. 
Two kinds of monomers were prepared, which have the different spacer structures between 
3,5-bis(4-aminophenoxy)phenyl and PC groups. If the longer and flexible spacer could be 
introduced into the monomer structure, it is expected that the PC group in the polymer 
would be easily oriented on the surface because of the mobility of flexible spacer. Then, two 
compounds, 6a and 6b, were prepared as intermediates, which were obtained by the 
esterification of 5 with ethylene glycol and tri(ethylene glycol), respectively. From 6a and 6b, 
the two diamine monomers, BAPPC-1 and 2, were prepared according to the same pathway 
as the preparation of DAPC in Scheme 1. Although the several reaction steps are necessary 
to prepare these monomers, all of the reaction steps proceeded smoothly in high yields. This 
novel diamine monomers, BAPPC-1 and 2, would be useful for the synthesis of various 
aromatic polymers which has PC group in the side chain. 
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Scheme 2. Synthesis of diamine monomers containing PC moiety (BAPPC). 
3. Aromatic polyamides containing phospholipid moiety 
In general, the aromatic polyamides are insoluble in many solvents, thermally stable up to 
300℃ and mechanically tough materials, which are used in a lot of electric devices and 
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motorcars. Therefore, we attempted to prepare aromatic polyamides containing PC group in 
the side chain by using the PC-containing diamine monomers, which would lead to new 
biocompatible polyamides derived from the characteristics of phospholipid moiety. 
3.1 Preparation 
The preparations of copolyamides were carried out by the polycondensations of BAPPC-1 or 
2 with isophthaloyl chloride and another diamine comonomer, as shown in Scheme 3. As 
the comonomer, 2,2-Bis[4-(amino-phenyloxy)phenyl]propane (BAP) was used to make the 
polymer soluble in some solvents. On the other hand, a polyamide without PC group (PA) 
was prepared from BAP and isophthaloyl chloride to compare the physical property with 
PC-containing copolyamides. Table 1 summarizes the results of polymerizations. Eight 
kinds of copolyamides with different spacer structures and contents of PC unit were 
prepared by changing the ratio of monomers in the feed of polymerization. The obtained 
copolyamides had the number-average molecular weights (Mn) more than 105., while the 
Mn of polyamides prepared from DAPC in Scheme 1 was in the order of 103 – 104. 
Therefore, it is suggested that this novel diamine monomer containing PC group has high 
reactivity in the polymerization, and would be useful for the preparations of other high 
molecular weight polymers such as polyimide and polyurea containing PC group. 
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Scheme 3. Preparation of copolyamide containing PC moiety (CPAPC). 
 
Code               m             BAPPC/BAP          x/ya)        (x104)       Mw/Mnb)
CPAPC-1a       
CPAPC-1b              
CPAPC-1c
CPAPC-1d              
CPAPC-2a
CPAPC-2b
CPAPC-2c
CPAPC-2d
      PA
  24/76           18.2           4.03
  46/54           57.9           2.01
  54/46           59.1           2.05
100/ 0              --                --
  28/72           11.3           3.21
  45/55           22.8           3.14
  57/43           24.9           3.31
100/ 0            36.0           2.06
    0/100         49.0           2.34   
a) The copolymer composition, x/y, was determined by 1H-NMR.
b) Number-average and weight-average molecular weights (Mn and Mw) 
    were estimated by gel permeation chromatgraphy using DMF as eluent.
Composition (mol%)
1                    30/70
1                    50/50
1                    70/30
1                  100/ 0
3                    30/70 
3                    50/50 
3                    70/30
3                  100/ 0
--                     0/100 
Mnb)
 
Table 1. Results of polycondensations. 
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These copolyamides were soluble in aprotic polar solvents, such as dimethylformamide 
(DMF), dimethylsulfoxide (DMSO) and N-methyl-2-pyrrolidinone (NMP), at room 
temperature, whereas they were insoluble in water, methanol, ethanol, acetone and other 
ordinary organic solvents. This solubility in specific solvents is advantageous in the 
processing for medical devices, and the insolubility in other solvents enables the material 
durable. On the other hand, PC-containing homopolyamides, CPAPC-1d and CPAPC-2d in 
Table 1, exhibited the less solubility than the copolyamides. For example, CPAPC-1d was 
insoluble in DMF, therefore, the gel permeation chromatography to determine the molecular 
weight could not be measured. It is considered that such homopolyamides with high 
content of PC unit has a strong molecular interaction between polar PC group and amide 
bond or other PC group to make the polymer insoluble in solvents. Therefore, the 
copolymerization of BAPPC with other diamine monomer would be effective to obtain 
soluble and processable polymer material. 
3.2 Biocompatibility 
The blood compatibility of the copolyamide was evaluated by contacting the copolyamide 
films with human blood. Circular pieces of PET plates (diameter: 14 mm, thickness: 0.2 mm) 
were dipped in polymer solutions in NMP for 30 min, and the obtained polymer-coated PET 
plates were dried. Then, the homogeneous coating films on PET plates were prepared from 
CPAPC-2 series and other polymers. The polymer-coated PET plates were contacted with 
phosphate-buffered solution (PBS, pH=7.4) at r.t. for overnight to equilibrate the surface, 
then human whole blood or PRP was poured onto the plates and incubated for 60 min at 
37°C. After the incubation, whole blood and platelet-rich plasma (PRP) were removed with 
an aspirator, and the plates were rinsed three times with PBS, and then 0.7 ml of 2.5 vol.% 
glutaraldehyde in PBS was poured onto each plate, and the materials were maintained at 
room temperature for 2 h in order to fix the blood components on the plates. After the 
fixation, it had been rinsed five times with distilled water, and then the plate was freeze-
dried. The surfaces of the polymer-coated plates were observed with a scanning electron 
microscope (SEM), and the number of adhered platelets was estimated by the procedure 
written in our literature (Nagase et al., 2007). 
Fig. 2 shows the SEM pictures of PA and CPAPC-2c and 2d film surfaces after contact with 
PRP. As seen in this figure, it was clarified that the large aggregates of the human platelets 
occurred on polyamide (PA) film, where a lot of adhered platelets were observed. On the 
contrary, PC-containing copolyamide films resisted the adhesion of platelets.  
 
PA CPAPC-2c CPAPC-2d
10 µm10 µm10 µm
 
Fig. 2. SEM pictures of polyamide film surfaces with and without PC unit after contact with 
human PRP. (x 2,000) 
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Fig. 3. Number of adhered platelets on the polymer films after contact with human PRP  
for 1 h. 
The quantitative analysis of adhered platelets of each polymer film was also carried out to 
reveal the strict difference of thrombogenic property of these polymer films. Fig. 3 
represents the difference of the number of platelets that adhered on each coated film. In this 
figure, the data of MPC polymer and other kinds of PC-containing polyamides, CPAPC-3 
and HPAPC, are included to compare with PA and CPAPC-2 series. CPAPC-3 is a similar 
copolymer to CPAPC-2 series, the comonomer of which is 1,6-diaminohexane instead of 
BAP. HPAPC is a homopolyamide obtained from the polycondensation of BAPPC-2 with 
4,4’-(4-carboxylphenoxy)-2,2-diphenylpropane, which has a good solubility in aprotic polar 
solvents. MPC polymer coated film has been also evaluated, because it is a good reference as 
the very high biocompatible material. 
As shown in Fig. 3, it was obvious that PC-containing polyamides efficiently reduced the 
adhered platelets than polyamide without PC group (PA), where the number of adhered 
platelets of these polyamides was reduced in nearly one-tenth amount as compared with 
that of PA. These results indicate that the PC unit plays an important role for the blood 
compatibility of the polymers. Furthermore, the amount of adhered platelets decreased as 
the increase of the content of PC unit in CPAPC-2 series, therefore, the composition of the 
PC unit was a dominant factor in the reduction of the blood cell and platelet adhesion. For 
example, the amount of adhered platelets of CPAPC-2a (PC content: 28 mol%) was ten times 
larger than that of CPAPC-2d (PC content: 100 mol%). The similar tendency was observed 
for CPAPC-1 series (Horiguchi et al., 2008). Therefore, the difference of the spacer structure 
of these copolyamides would not affect the biocompatibility. On the other hand, MPC 
polymer exhibited the extremely high nonthrombogenicity among the polymers evaluated 
in Fig. 3. Consequently, the improvement of nonthrombogenicity by introducing PC unit in 
such polyamide system would be limited, although the phospholipid moiety is effective to 
considerable extent for the reduction of the platelet and protein adhesion. 
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3.3 Physical property 
The thermal property of PC-containing polyamides was evaluated by differential scanning 
calorimetry (DSC) and thermogravimetric analysis (TGA). The glass transition temperature 
(Tg) and the melting temperature (Tm) were not observed for CPAPC-1 and 2 series in the 
range between -100°C and 250°C of DSC thermograms, which suggested that these 
polyamides were glassy polymers. In general, aromatic polyamides are known to exhibit a 
crystalline state, however, bulky PC group in the side chain would prevent the 
crystallization of polyamide backbone.  
Fig. 4 shows the TGA curves of PA and CPAPC-1b and 2b under N2 flow. As seen in this 
figure, the thermal degradation of homopolyamide, PA, started at about 400°C, but the PC-
containing copolyamides degraded at about 250°C. This would be due to the thermal 
degradation of polymer side chain, which consisted of the PC or spacer moiety. In nitrogen 
atmosphere, the aromatic backbone would be carbonized, which resulted in the residue 
more than 30 % at 1000°C. In the case of the copolyamides, the phosphate moiety would be 
incombustible, where the residue was a little higher, nearly 50 %. Anyhow, the heat 
resistance of these PC-containing polyamides until 250°C is enough to use for biomaterial 
devices, for example, for the thermal sterilization process over 150°C. 
The very tough films could be obtained from PC-containing copolyamides by solvent 
casting method. Then, the mechanical properties of these copolyamides and MPC polymer 
films were quite different, where Young’s moduli of the copolyamides, PA and MPC 
polymer films were 200-400, 642 and 15.2 MPa, respectively. Therefore, the physical 
properties of PC-containing copolyamides obviously depended on the aromatic polyamide 
backbone. Consequently, it is expected that the aromatic copolyamides containing PC group 
will be useful polymeric biomaterials to develop a new generation of biomedical devices, 
because of the durability to solvents, the high thermal stability and mechanical strength in 
addition to the good biocompatibility. 
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Fig. 4. TGA curves of polyamides at heating rate of 10°C/min in N2 flow. 
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4. Segmented poly(urethane-urea) containing phospholipid moiety 
Segmented polyurethanes have been widely used in the practical medical devices as 
elastomers (Lelah, 1986; Eisenbach, 1996) because of their suitable mechanical properties 
and biocompatibility, which consisted of short alternating blocks of soft and hard segments. 
The soft segment is typically a low glass transition temperature (Tg) polyether, polyester or 
polycarbonate, the molecular weights of which are 400-2000. The hard segment is usually a 
high Tg component, such as semicrystalline aromatic diisocyanate linked with a low 
molecular weight chain extender. The biocompatibility of segmented polyurethane is 
thought to be derived from the micro phase separation of soft and hard segments. However, 
the blood compatibility of segmented polyurethane is not enough to be applied for long-
term implantation. It has been suggested that the biodegradation and cracking of 
polyurethane occurred in vivo due to the adsorption of proteins, the adhesion of 
macrophages and the peroxide formation (Zao et al., 1991, 1993; Wu et al., 1991), which 
resulted in the reduction of the mechanical strength of SPU. Moreover, it was reported that 
the soft segment of segmented polyurethane was degraded by the oxygen radicals produced 
from adherent macrophages (Stokes et al., 1995). Therefore, several studies of the surface or 
chemical modification of segmented polyurethanes have been conducted to improve the 
blood compatibility through reducing the adhesion of cells and proteins (Kang et al., 1997; 
Flemming et al., 1999; Mathur et al., 1997; Roh et al., 1999; Lee et al., 2000). The composite 
material of segmented polyurethane and MPC polymer has been also reported, which 
showed the high biocompatibility and the elasticity (Ishihara et al., 2000). 
In our study, as another approach to improve the biocompatibility of segmented 
polyurethane which has been widely used as a biomedical material, we attempted to 
prepare segmented poly(urethane-urea) containing PC group by using the PC-containing 
diamine monomer as a coupling reagent in the polyaddition of diols with diisocyanate, 
which was expected as new biocompatible polymers by combining the characteristics of 
segmented polyurethane and phospholipid moiety.  
4.1 Preparation 
As shown in Scheme 3, segmented polyurethane was first prepared by polyaddition of 4,4’-
diphenylmethane diisocyanate (MDI) with 1,4-butanediol (BD) in NMP, followed by the 
addition of hydroxyl-terminated poly(tetramethylene glycol) (PTMG) as the soft segment.  
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Scheme 3. Preparation of segmented poly(urethane-urea) containing PC moiety (SPUPC). 
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Next, in the polymerization vessel, PC-containing diamine monomer, BAPPC-1 or 2, was 
added to couple the polyurethane to obtain segmented poly(urethane-urea)s containing PC 
unit (SPUPC-1 and 2). These polymerization reactions proceeded smoothly without catalyst. 
By the way, dibutyltin dilaurate was necessary as a catalyst for the preparation of the similar 
segmented poly(urethane-urea) using DAPC in Scheme 1 (Nagase, et al., 2008). 
Table 2 summarizes the results of polymerizations. A few poly(urethane-urea)s with 
different contents of PC unit were prepared by changing the amount of BD, PTMG and 
BAPPC-1 or 2 in the polyaddition. The chemical structures of these polymers were 
confirmed by their 1H-NMR and IR spectra. The compositions of PC unit in these 
copolymers were determined from the ratio of the peak intensities of the ammonium 
protons (3.10 - 3.15 ppm) of PC unit and methylene proton (3.78 – 3.80 ppm) of p,p’-
diphenylmethane unit, which existed in every monomer components. In the gel permeation 
chromatography, bimodal peaks were observed in most of these copolymers. Thus, each 
two values were listed in Table 2 as the number-average molecular weights (Mn) of the 
obtained copolymers, which were in the range of 104 and 106. Probably, the higher molecular 
weight segments over 106 would be partly produced in the final coupling reaction with 
BAPPC-1 or 2. Anyhow, very high molecular weight poly(urethane-urea)s containing 
phospholipid moiety have been successfully prepared by polyaddition with PC-containing 
diamine monomers. 
 
Code             m   BD/PTMG/BAPPCa)  (mol%) (wt.%)        (x104)         Mw/Mnb)
SPUUPC-1a  
SPUUPC-1b  
SPUUPC-1c   
SPUUPC-2a   
SPUUPC-2b   
SPUUPC-2c
       SPU
   1.86              1.88
7.47, 254      1.85, 1.03
1.35,  99.0    1.78, 1.87
2.19, 210      1.74, 1.15
2.01, 120      1.51, 1.57
2.19, 111      1.82, 1.47
a) The molar ratio of monomers in the polyaddition. 
b) Number-average and weight-average molecular weights (Mn and Mw) were 
    estimated by gel permeation chromatgraphy using DMF as eluent.
PC content            Mnb)
14          2.5
27          9.1
47        22
15          6.3
28        13
49        25
  0          0               2.62              1.46
1
1
1
3
3
3
--
50 / 33 / 17
33 / 34 / 33
17 / 33 / 50
50 / 33 / 17
33 / 34 / 33
17 / 33 / 50
67 / 33 /   0
 
Table 2. Results of polyadditions. 
The obtained poly(urethane-urea)s exhibited a good solubility in aprotic polar solvents such 
as NMP, DMF and DMSO at room temperature, whereas it was insoluble in methanol, 
ethanol, acetone, chloroform and water. Such solubility in the specific solvents is 
advantageous in the processing for medical devices, and the insolubility in other solvents 
enables the material durable to these solvents. Actually, flexible and self-standing films 
could be prepared from these copolymers by a solvent casting method.    
4.2 Biocompatibility 
The blood compatibility of the poly(urethane-urea) films was evaluated by the similar 
procedure described in Section 3.2. For this experiment, the self-standing films prepared 
from each copolymer were used, not coating film. Fig. 5 shows the number of platelets 
adhered on the polymer films after contact with PRP for 1 h. It was found that the platelet 
adhesion was suppressed to a certain extent even on SPU film without PC unit, where the 
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amount of adhered platelets was quite different from the values of polyamide (PA) shown 
in Fig. 3. Therefore, segmented polyurethane would have the higher non-thrombogenic 
efficiency than aromatic polyamide and other normal polymer materials. Furthermore, PC-
containing poly(urethane-urea)s, SPUPC-2b and SPUPC-2c, efficiently reduced the platelet 
adhesion rather than SPU, and the number of adhered platelets of these copolymer films 
were almost same as that of MPC polymer film. Furthermore, the composition of PC unit 
was a dominant factor in the reduction of the blood cell and platelet adhesion, which was 
revealed from the result that the number of adhered platelets was much decreased on 
SPUPC-2c film rather than SPUPC-2a and SPUPC-2b films. Thus, the PC content of 25 wt.% 
in SPUPC-2c would be necessary to sufficiently reduce the platelet adhesion on the polymer 
surfaces, which would be an enough content of the PC unit located at the surface of the 
polymer film. The surface chemical structure of SPUPC-2c film was analyzed by X-ray 
photoelectron spectroscopy (XPS). The XPS signals was observed at 133, 398 and 402 eV in 
P2p and N1s regions, which were attributed to the phosphorus of the phosphate group, the 
nitrogen atoms in the urethane or urea bond (-NH-) and the ammonium group (-N+(CH3)3), 
respectively. Then, PC group was clearly observed on the SPUPC-2c film surface. However, 
these peaks were not so clear on the surfaces of SPUPC-2a and 2b films. Therefore, in this 
poly(urethane-urea) system, PC content should be over ca. 25 wt.% to make the PC group 
clearly appear on the surface of polymer film. In addition, it was found from the surface 
analysis, that the PC group was easily rearranged by the immersion in water. 
Moreover, such PC-containing poly(urethane-urea), SPUPC series, has the higher 
biocompatibility than PC-containing polyamide, CPAPC series, which would be due to the 
additive effect of PC unit to the potential biocompatibility of segmented polyurethane. 
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Fig. 5. Amount of adhered platelets on segmented polyurethane, poly(urethane-urea) and 
MPC polymer films after contact with human PRP for 1 h. 
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4.3 Mechanical property 
From the results of DSC and TGA measurements, PC-containing poly(urethane-urea)s were 
glassy polymers, Tg of which was not observed in the range of -50°C - 250°C, and the 
thermal degradation temperature was confirmed at around 250°C. This is a similar thermal 
behavior as PC-containing polyamides. The characteristic property of such a polyurethane 
material is a mechanical strength and elasticity. Then, the stress-strain behaviors of PC-
containing poly(urethane-urea) films were evaluated in order to reveal the effect of 
introduction of PC unit on the mechanical property of polyurethane backbone. 
Fig. 6 shows the stress-strain behaviors of SPUPC-2a, 2b and 2c films, and the Young’s 
modulus, the tensile strength and the elongation to break were summarized in the table as 
compared with those of SPU. The similar tendency of stress-strain curve was observed in SPU 
film, although the Young’s moduli and elongations were different. Therefore, there was almost 
no change in such elastic stress-strain behaviors between SPU and SPUPC series. Young’s 
moduli of SPUPC series increased with the increase of PC unit, as listed in the table of Fig. 6. It 
would be due to the increase of urea bond, which would enhance the molecular interaction in 
the hard segments rather than urethane bond. Consequently, the physical properties of these 
poly(urethane-urea)s obviously depended on the elastic segmented polyurethane backbone. 
 
Code
SPU 
SPUUPC-2a
SPUUPC-2b
SPUUPC-2c
Tensile
strength
(MPa)
21.2
29.6
19.8
21.8
Elongation
to break
(%)
1010 
645
442
255
Young’s
modulus
　 (MPa)
106
31.6
82.0
267
S
tr
es
s 
(M
P
a)
Strain (%)
SPUPC-2c
SPUPC-2b
SPUPC-2a
 
Fig. 6. Stress-strain behaviors of SPUPC films. 
Taking such mechanical property into account, we have attempted to prepare the elastic 
tube from these polyurethane materials. A stainless steel stick (4 mmφ) was dipped in 5 
wt.% SPUPC-2c solution in NMP and dried at 70°C. This procedure was repeated six times, 
and the copolymer was coated on the stainless steel stick. Then, the coated stick was coated 
again with poly(carbonate urethane) (Bionate® 80A, Asahi Chemical Co.) by the same 
procedure. After dried, the stainless steel was pulled out carefully to obtain the flexible tube 
consisted of the composite polyurethanes. The picture of the obtained tube is shown in Fig. 
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7(a). Fig. 7(b) represents a cross section of the tube by the observation of SEM. In addition, 
the both side surfaces of the tube were analyzed by XPS, as shown in Fig. 7(c). The 
phosphorus of PC group was clearly observed inside of the tube at 133 eV, and the outside 
was confirmed to be coated by poly(carbonate urethane) without PC unit. Therefore, 
SPUPC-2c/poly(carbonate urethane) composite tube could be successfully prepared. 
 
20.0kV    ×500     50µm
127133139145
Binding energy (eV)
127133139145
Binding energy (eV)
Inside:
SPUPC-2c
Outside:
PCU 
P2p
(a)
(b) (c)
 
Fig. 7. Polyurethane composite tube made from SPUPC-2c and poly(carbonate urethane) 
(PCU). (a) Pictures of the tube. (b) SEM picture of the cross section of the tube. (c) XPS 
spectra of inside and outside of the tube. 
The obtained tube has an elastic property derived from segmented polyurethane, and it is 
expected as artificial blood tube or catheter. The evaluations of this material for implant 
applications will be carried out in the future, although biomedical researchers are necessary 
as co-workers for the experiments. 
5. Conclusion 
This chapter covered the subject of our recent study to develop new biomaterials containing 
a phospholipid moiety. A novel aromatic diamine monomer containing PC group could be 
synthesized to prepare polycondensation or polyaddition type polymers. The PC-containing 
aromatic copolyamides and segmented poly(urethane-urea)s were successfully prepared 
from the monomer compound. Regarding the effect of PC group on the blood compatibility, 
the introduction of such a polar group of phospholipid was effective to appear the blood 
compatibility even in the aromatic copolyamides and segmented poly(urethane-urea)s. It is 
expected that these copolymers containing PC group will be useful polymeric biomaterials 
to develop a new generation of biomedical devices, because of the different solubility, the 
higher thermal stability and the similar biocompatibility as compared to MPC polymer. In 
addition, aromatic polyamides are hard materials, while segmented poly(urethane-urea)s 
are soft and elastic materials owing to the nature of main chain components. Therefore, we 
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can add the several mechanical properties on PC-containing polymers according to any 
demands of medical applications. For example, the hard material is useful for artificial bone 
or joint, and the soft and elastic material will be used for artificial blood tube or catheter.  
It has been also revealed that the biocompatibility is improved satisfactorily as the increase 
of PC content in the copolymer. However, in the case of these polycondensation or 
polyaddition type polymers, it is a problem that the solubility in organic solvents becomes 
poor as the PC content increases. It would be due to the high molecular interaction between 
side chain PC group and polar group in main chain, such as amide or urea bond. 
Furthermore, in the case of poly(urethane-urea) system, the increase of urea unit containing 
PC moiety let the polymer lose the elasticity owing to the aggregation between urea bonds. 
To solve these problems, we have designed a new diol monomer containing PC moiety, 
which will be able to yield PC-containing polyurethanes or polyesters. By using the diol 
monomer, polyurethanes or polyesters with high content of PC unit will be developed, 
which is now in progress. 
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